TRAVELLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 986
AS - Asia 795
EU - Europa 563
SA - Sud America 135
AF - Africa 58
OC - Oceania 3
Totale 2.540
Nazione #
US - Stati Uniti d'America 959
SG - Singapore 241
CN - Cina 206
HK - Hong Kong 138
IE - Irlanda 127
RU - Federazione Russa 110
BR - Brasile 108
VN - Vietnam 84
IT - Italia 80
DE - Germania 75
FR - Francia 46
FI - Finlandia 43
ZA - Sudafrica 35
GB - Regno Unito 31
IN - India 29
IQ - Iraq 16
JP - Giappone 12
MX - Messico 11
AR - Argentina 10
BD - Bangladesh 10
CA - Canada 10
BE - Belgio 9
ES - Italia 9
MA - Marocco 8
CO - Colombia 7
ID - Indonesia 6
PH - Filippine 6
PK - Pakistan 6
SA - Arabia Saudita 6
TR - Turchia 6
AT - Austria 5
EG - Egitto 5
PL - Polonia 4
SE - Svezia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
LT - Lituania 3
MY - Malesia 3
NL - Olanda 3
NP - Nepal 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
UA - Ucraina 2
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.540
Città #
Hong Kong 137
San Jose 132
Singapore 129
Dublin 127
Chandler 113
Ashburn 109
Dallas 93
Beijing 75
Boardman 41
Lauterbourg 40
Munich 40
Johannesburg 30
Redondo Beach 30
Ho Chi Minh City 29
Los Angeles 28
Helsinki 25
New York 20
Orem 20
Shanghai 20
Moscow 19
Buffalo 18
The Dalles 18
Turku 18
Council Bluffs 16
Hanoi 16
Ann Arbor 15
Falkenstein 15
Lawrence 15
Princeton 15
Milan 14
Nuremberg 13
São Paulo 13
Medford 11
Chicago 10
Tokyo 10
Baghdad 9
Bolzaneto 9
Brussels 9
Wilmington 9
Santa Clara 8
Guangzhou 7
Brooklyn 6
Da Nang 6
Manchester 6
Mexico City 5
San Francisco 5
Bossico 4
Columbus 4
Fortaleza 4
Mumbai 4
Norwalk 4
Novara 4
Rio de Janeiro 4
Rome 4
Washington 4
Biên Hòa 3
Boston 3
Casablanca 3
Charlotte 3
Chennai 3
Haiphong 3
Hangzhou 3
Houston 3
Inverigo 3
Jeddah 3
Joinville 3
Londrina 3
Medellín 3
Montreal 3
Nairobi 3
Richmond 3
Salvador 3
Seattle 3
Seoul 3
Shijiazhuang 3
Stockholm 3
Tianjin 3
Turin 3
Warsaw 3
Amman 2
Ankara 2
Atlanta 2
Augusta 2
Barbianello 2
Barra Mansa 2
Belo Horizonte 2
Bengaluru 2
Brasília 2
Bắc Ninh 2
Cairo 2
Des Moines 2
Duque de Caxias 2
Durban 2
Faisalabad 2
Genoa 2
Greensboro 2
Gurugram 2
Islamabad 2
Istanbul 2
Jakarta 2
Totale 1.703
Nome #
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 113
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 102
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer 97
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents 92
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 89
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 87
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 84
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 84
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 82
Disruption of epithelial barrier integrity via altered GILZ/c-Rel/RACK1 signaling in inflammatory bowel disease (IBD) 81
Molecular regulations of circadian rhythm and implications for physiology and diseases 80
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers 79
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 77
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 77
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 76
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 75
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 74
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 70
Prostaglandin E2 and cancer: Insight into tumor progression and immunity 70
Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis 67
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer 63
eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage 57
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 55
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 54
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 54
NAMPT: A pleiotropic modulator of monocytes and macrophages 52
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 52
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 51
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? 48
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 46
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy 44
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 44
NAD depletion by FK866 induces autophagy 43
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 41
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 40
Characterization of NAD uptake in mammalian cells 40
Metabolic regulation of suppressive myeloid cells in cancer 39
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 38
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 36
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 32
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 31
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 27
Totale 2.643
Categoria #
all - tutte 12.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 1 1
2021/202297 1 1 1 0 2 1 0 7 5 1 10 68
2022/2023317 17 34 15 22 22 34 0 18 143 2 8 2
2023/2024108 9 13 6 11 17 29 0 20 1 1 0 1
2024/2025710 38 45 10 49 2 48 62 30 155 18 111 142
2025/20261.392 126 111 164 125 203 51 280 82 134 116 0 0
Totale 2.643